{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:13:33Z","timestamp":1779293613734,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00198-026-07887-w","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:34:32Z","timestamp":1771241672000},"page":"945-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychotropic medication use and bone fracture risk among patients with multiple sclerosis: a real-world study"],"prefix":"10.1007","volume":"37","author":[{"given":"Po-Chun","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-En","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-An","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0470-2184","authenticated-orcid":false,"given":"Sheng-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"14","key":"7887_CR1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler 26(14):1816\u20131821","journal-title":"Mult Scler"},{"issue":"10","key":"7887_CR2","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1038\/s41591-025-03901-6","volume":"31","author":"H Ganjgahi","year":"2025","unstructured":"Ganjgahi H, H\u00e4ring DA, Aarden P, Graham G, Sun Y, Gardiner S et al (2025) AI-driven reclassification of multiple sclerosis progression. Nat Med 31(10):3414\u20133424","journal-title":"Nat Med"},{"issue":"6","key":"7887_CR3","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00415-025-13128-7","volume":"272","author":"E Gervasoni","year":"2025","unstructured":"Gervasoni E, Torchio A, Bertoni R, Chieffo R, Rocca MA, Pau M et al (2025) Beyond EDSS: multidomain impairments are detectable and associated with walking disorders in low-disabled people with multiple sclerosis. J Neurol 272(6):404","journal-title":"J Neurol"},{"issue":"5","key":"7887_CR4","doi-asserted-by":"publisher","first-page":"e70176","DOI":"10.1111\/ene.70176","volume":"32","author":"A Zinganell","year":"2025","unstructured":"Zinganell A, Hegen H, Walde J, Barket R, Berek K, Auer M et al (2025) Short-term risk factors for bone loss in multiple sclerosis: a prospective study and literature review. Eur J Neurol 32(5):e70176","journal-title":"Eur J Neurol"},{"issue":"22","key":"7887_CR5","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1212\/WNL.0000000000002174","volume":"85","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Fisk JD, Tremlett H, Wolfson C, Warren S, Tennakoon A et al (2015) Differences in the burden of psychiatric comorbidity in MS vs the general population. Neurology 85(22):1972\u20131979","journal-title":"Neurology"},{"issue":"3","key":"7887_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/1352458514564487","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS et al (2015) The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler 21(3):305\u2013317","journal-title":"Mult Scler"},{"key":"7887_CR7","doi-asserted-by":"publisher","unstructured":"Schenk A, Popa CO, Cojocaru CM, Marian \u0218, Maier S, B\u0103la\u0219a R (2024) Neuroticism as a common factor in depression and anxiety associated with multiple sclerosis-a systematic review and meta-analysis. Int J Environ Res Public Health 21(10). https:\/\/doi.org\/10.3390\/ijerph21101264","DOI":"10.3390\/ijerph21101264"},{"issue":"9","key":"7887_CR8","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1007\/s00415-022-11169-w","volume":"269","author":"MA Battaglia","year":"2022","unstructured":"Battaglia MA, Bezzini D, Cecchini I, Cordioli C, Fiorentino F, Manacorda T et al (2022) Patients with multiple sclerosis: a burden and cost of illness study. J Neurol 269(9):5127\u20135135","journal-title":"J Neurol"},{"issue":"18","key":"7887_CR9","doi-asserted-by":"publisher","first-page":"e1810","DOI":"10.1212\/WNL.0000000000200150","volume":"98","author":"B Bebo","year":"2022","unstructured":"Bebo B, Cintina I, LaRocca N, Ritter L, Talente B, Hartung D et al (2022) The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs. Neurology 98(18):e1810\u2013e1817","journal-title":"Neurology"},{"issue":"12","key":"7887_CR10","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1474-4422(10)70249-0","volume":"9","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Toosy AT, Ciccarelli O (2010) Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol 9(12):1182\u20131199","journal-title":"Lancet Neurol"},{"issue":"6","key":"7887_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jamapsychiatry.2017.0449","volume":"74","author":"JM Bolton","year":"2017","unstructured":"Bolton JM, Morin SN, Majumdar SR, Sareen J, Lix LM, Johansson H et al (2017) Association of mental disorders and related medication use with risk for major osteoporotic fractures. JAMA Psychiat 74(6):641\u2013648","journal-title":"JAMA Psychiat"},{"issue":"3","key":"7887_CR12","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","volume":"51","author":"R Rizzoli","year":"2012","unstructured":"Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML et al (2012) Antidepressant medications and osteoporosis. Bone 51(3):606\u2013613","journal-title":"Bone"},{"issue":"6","key":"7887_CR13","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00198-005-0065-y","volume":"17","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17(6):807\u2013816","journal-title":"Osteoporos Int"},{"issue":"12","key":"7887_CR14","first-page":"1331","volume":"29","author":"M Cahyadi","year":"2023","unstructured":"Cahyadi M, Mesinovic J, Chim ST, Ebeling P, Zengin A, Grech L (2023) Medication and bone health in multiple sclerosis: a systematic review and meta-analysis. J Manag Care Spec Pharm 29(12):1331\u20131353","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"7887_CR15","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/ije\/dyz261","volume":"49","author":"MR Blum","year":"2020","unstructured":"Blum MR, Tan YJ, Ioannidis JPA (2020) Use of E-values for addressing confounding in observational studies-an empirical assessment of the literature. Int J Epidemiol 49(5):1482\u20131494","journal-title":"Int J Epidemiol"},{"issue":"7382","key":"7887_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326(7382):219","journal-title":"BMJ"},{"issue":"10430","key":"7887_CR17","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0140-6736(23)02800-3","volume":"403","author":"GD Mishra","year":"2024","unstructured":"Mishra GD, Davies MC, Hillman S, Chung HF, Roy S, Maclaran K et al (2024) Optimising health after early menopause. Lancet 403(10430):958\u2013968","journal-title":"Lancet"},{"issue":"25","key":"7887_CR18","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1161\/CIR.0000000000000912","volume":"142","author":"SR El Khoudary","year":"2020","unstructured":"El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD et al (2020) Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation 142(25):e506\u2013e532","journal-title":"Circulation"},{"issue":"5","key":"7887_CR19","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2022.24140","volume":"329","author":"CJ Crandall","year":"2023","unstructured":"Crandall CJ, Mehta JM, Manson JE (2023) Management of menopausal symptoms: a review. JAMA 329(5):405\u2013420","journal-title":"JAMA"},{"issue":"12","key":"7887_CR20","doi-asserted-by":"publisher","first-page":"102326","DOI":"10.1016\/j.jacadv.2025.102326","volume":"4","author":"O Badwan","year":"2025","unstructured":"Badwan O, Motairek I, Zghyer F, Puri R, Reed G, Krishnaswamy A et al (2025) Frailty predicts geriatric and cardiovascular adverse outcomes after TAVR: a 5-year real-world analysis. JACC Adv 4(12):102326","journal-title":"JACC Adv"},{"issue":"2","key":"7887_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jamcollsurg.2017.11.005","volume":"226","author":"S Subramaniam","year":"2018","unstructured":"Subramaniam S, Aalberg JJ, Soriano RP, Divino CM (2018) New 5-factor modified frailty index using American College of Surgeons NSQIP data. J Am Coll Surg 226(2):173\u201381.e8","journal-title":"J Am Coll Surg"},{"issue":"9","key":"7887_CR22","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/jbmr.418","volume":"26","author":"MT Bazelier","year":"2011","unstructured":"Bazelier MT, van Staa T, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P et al (2011) The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res 26(9):2271\u20132279","journal-title":"J Bone Miner Res"},{"issue":"7","key":"7887_CR23","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00198-014-2705-6","volume":"25","author":"S Pouwels","year":"2014","unstructured":"Pouwels S, de Boer A, Leufkens HG, Weber WE, Cooper C, van Staa TP et al (2014) Risk of fracture in patients with Guillain-Barr\u00e9 syndrome. Osteoporos Int 25(7):1845\u20131851","journal-title":"Osteoporos Int"},{"issue":"9","key":"7887_CR24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/phar.2849","volume":"43","author":"J Davis","year":"2023","unstructured":"Davis J, Casteel C, Brown G, Carnahan R (2023) Fracture risk and opioid use in patients aged 17-64\u2009years: an analysis of administrative claims data. Pharmacotherapy 43(9):913\u2013921","journal-title":"Pharmacotherapy"},{"issue":"24","key":"7887_CR25","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1212\/WNL.0b013e318259e0ff","volume":"78","author":"MT Bazelier","year":"2012","unstructured":"Bazelier MT, van Staa TP, Uitdehaag BM, Cooper C, Leufkens HG, Vestergaard P et al (2012) Risk of fractures in patients with multiple sclerosis: a population-based cohort study. Neurology 78(24):1967\u20131973","journal-title":"Neurology"},{"issue":"3","key":"7887_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40266-022-00929-y","volume":"39","author":"RE Virnes","year":"2022","unstructured":"Virnes RE, Tiihonen M, Karttunen N, van Poelgeest EP, van der Velde N, Hartikainen S (2022) Opioids and falls risk in older adults: a narrative review. Drugs Aging 39(3):199\u2013207","journal-title":"Drugs Aging"},{"issue":"12","key":"7887_CR27","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s11606-025-09499-2","volume":"40","author":"E Brunner","year":"2025","unstructured":"Brunner E, Chen CA, Klein T, Maust D, Mazer-Amirshahi M, Mecca M et al (2025) Joint clinical practice guideline on benzodiazepine tapering: considerations when risks outweigh benefits. J Gen Intern Med 40(12):2814\u20132859","journal-title":"J Gen Intern Med"},{"issue":"7","key":"7887_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/aje\/kwab042","volume":"190","author":"EJ Peach","year":"2021","unstructured":"Peach EJ, Pearce FA, Gibson J, Cooper AJ, Chen LC, Knaggs RD (2021) Opioids and the risk of fracture: a self-controlled case series study in the clinical practice research datalink. Am J Epidemiol 190(7):1324\u20131331","journal-title":"Am J Epidemiol"},{"issue":"10","key":"7887_CR29","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1111\/jgs.70031","volume":"73","author":"M Pan","year":"2025","unstructured":"Pan M, Duchesneau ED, Miller EM, Her QL, Pate V, Faurot KR et al (2025) Patterns of benzodiazepines and hypnotic drugs dispensing after hip fracture among older US adults previously on the drugs. J Am Geriatr Soc 73(10):3095\u20133104","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"7887_CR30","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.amjmed.2005.07.033","volume":"118","author":"M Kinjo","year":"2005","unstructured":"Kinjo M, Setoguchi S, Schneeweiss S, Solomon DH (2005) Bone mineral density in subjects using central nervous system-active medications. Am J Med 118(12):1414","journal-title":"Am J Med"},{"key":"7887_CR31","doi-asserted-by":"publisher","unstructured":"Wehbeh L, Dobs AS (2020) Opioids and the hypothalamic-pituitary-gonadal (HPG) axis. J Clin Endocrinol Metab 105(9). https:\/\/doi.org\/10.1210\/clinem\/dgaa417","DOI":"10.1210\/clinem\/dgaa417"},{"issue":"3","key":"7887_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000054586","volume":"72","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2000","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Olmos JM, G\u00f3mez JJ, Barrallo A, Riancho JA, Perera L et al (2000) Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology 72(3):187\u2013194","journal-title":"Neuroendocrinology"},{"issue":"1","key":"7887_CR33","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.biopsych.2012.11.003","volume":"74","author":"JM Hodge","year":"2013","unstructured":"Hodge JM, Wang Y, Berk M, Collier FM, Fernandes TJ, Constable MJ et al (2013) Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol Psychiatry 74(1):32\u201339","journal-title":"Biol Psychiatry"},{"issue":"3","key":"7887_CR34","doi-asserted-by":"publisher","first-page":"101793","DOI":"10.1016\/j.berh.2022.101793","volume":"36","author":"M Urquiaga","year":"2022","unstructured":"Urquiaga M, Saag KG (2022) Risk for osteoporosis and fracture with glucocorticoids. Best Pract Res Clin Rheumatol 36(3):101793","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"7887_CR35","doi-asserted-by":"publisher","first-page":"e0149888","DOI":"10.1371\/journal.pone.0149888","volume":"11","author":"MH de Groot","year":"2016","unstructured":"de Groot MH, van Campen JP, Kosse NM, de Vries OJ, Beijnen JH, Lamoth CJ (2016) The association of medication-use and frailty-related factors with gait performance in older patients. PLoS ONE 11(2):e0149888","journal-title":"PLoS ONE"},{"issue":"4","key":"7887_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","volume":"23","author":"P Vestergaard","year":"2012","unstructured":"Vestergaard P, Hermann P, Jensen JE, Eiken P, Mosekilde L (2012) Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int 23(4):1255\u20131265","journal-title":"Osteoporos Int"},{"key":"7887_CR37","doi-asserted-by":"publisher","first-page":"677879","DOI":"10.3389\/fimmu.2021.677879","volume":"12","author":"E Stamoula","year":"2021","unstructured":"Stamoula E, Siafis S, Dardalas I, Ainatzoglou A, Matsas A, Athanasiadis T et al (2021) Antidepressants on multiple sclerosis: a review of in vitro and in vivo models. Front Immunol 12:677879","journal-title":"Front Immunol"},{"key":"7887_CR38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/jnnp-2022-329049","volume":"93","author":"L Prosperini","year":"2022","unstructured":"Prosperini L, Lucchini M, Ruggieri S, Tortorella C, Haggiag S, Mirabella M et al (2022) Shift of multiple sclerosis onset towards older age. J Neurol Neurosurg Psychiatry 93:1137\u20131139","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"7887_CR39","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/brain\/awae245","volume":"148","author":"RP Holm","year":"2025","unstructured":"Holm RP, Wandall-Holm MF, Magyari M (2025) Multiple sclerosis in Denmark (1950-2023): mean age, sex distribution, incidence and prevalence. Brain 148(2):626\u2013634","journal-title":"Brain"},{"issue":"12","key":"7887_CR40","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1177\/1352458520987541","volume":"27","author":"D Belvisi","year":"2021","unstructured":"Belvisi D, Canevelli M, Baione V, Buscarinu MC, Pellicciari G, Fantozzi R et al (2021) Operationalization of a frailty index in patients with multiple sclerosis: a cross-sectional investigation. Mult Scler 27(12):1939\u20131947","journal-title":"Mult Scler"},{"issue":"11","key":"7887_CR41","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/jnnp-2022-329169","volume":"93","author":"JS Willumsen","year":"2022","unstructured":"Willumsen JS, Grytten N, Aarseth J, Myklebust T, Myhr KM, Midgard R (2022) Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study. J Neurol Neurosurg Psychiatry 93(11):1154\u20131161","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"7887_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S1474-4422(12)70059-5","volume":"11","author":"JA Cohen","year":"2012","unstructured":"Cohen JA, Reingold SC, Polman CH, Wolinsky JS (2012) Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol 11(5):467\u2013476","journal-title":"Lancet Neurol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-026-07887-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-026-07887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:26:48Z","timestamp":1779290808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-026-07887-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7887"],"URL":"https:\/\/doi.org\/10.1007\/s00198-026-07887-w","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was deemed exempt by the Joint Institutional Review Board of Taipei Medical University (No. N202511077).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Because this study used a de-identified and de-linked database from the TriNetX Research Platform, the requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration"}},{"value":"Sheng-Feng Lin","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}}]}}